SYCP2 and invasive ductal breast carcinoma: In addition, we also analyzed the prognostic effects of SYCP2 in different subgroups, and the results showed that SYCP2 was a risk factor in the subgroup of T3 stage, N0, M0, and infiltrating ductal carcinoma (HR > 1 and p < 0.05) (Figure 9H).